Congratulations to Spinal Stabilization Technologies on beginning their LOPAIN2 clinical trial, measuring the efficacy of the PerQdisc Nucleus Replacement Device (NRD).
By // by PLS
Prepare to Prosper
Prepare to Prosper
Congratulations to Spinal Stabilization Technologies on beginning their LOPAIN2 clinical trial, measuring the efficacy of the PerQdisc Nucleus Replacement Device (NRD).
Allotrope Medical, Inc. Earns FDA Safer Technologies Program (STeP) Designation